Navigation Links
Wayne State researchers seek calcium channels to target cancer tumors
Date:4/22/2013

DETROIT Two Wayne State University researchers are working on a technique that could lead to easier, faster identification of cancer tumors that can be effectively treated by calcium channel-based therapies.

Rod Braun, Ph.D., associate professor of anatomy and cell biology in the School of Medicine, recently received a two-year, $322,000 grant from the National Cancer Institute of the National Institutes of Health to use manganese-enhanced magnetic resonance imaging (MEMRI) to noninvasively determine the activity of different calcium channels in tumors. He and co-principal investigator Bruce Berkowitz, Ph.D., professor of anatomy and cell biology and ophthalmology, and director of the School of Medicine's Small Animal MRI Facility, are hoping the technique can be used to guide and individualize calcium channel-based treatment of cancer.

Previous research has shown that different types of cancer cells highly express a number of plasma membrane calcium channels, making them important potential therapeutic targets in tumors. Drugs that target specific calcium channels already exist, and several are currently in Phase I clinical trials as anti-cancer agents.

"Unfortunately, it is difficult to determine whether a specifically targeted calcium channel is present in an individual patient's tumor," Braun said.

In their project, "Guiding Ca2+ Channel-Based Cancer Treatment Using Mn2+-Enhanced MRI," he and Berkowitz will use MEMRI to measure tumors' uptake of manganese ion, an MRI contrast agent that largely enters cells via calcium channels. They believe tumor uptake of manganese in the presence of antagonist compounds, which block calcium channels, and agonist compounds, which stimulate them, can be measured using MEMRI, thereby proving useful in predicting potential tumor response to calcium-channel based therapies.

The project has two components. The first will test manganese uptake of prostate, breast and colorectal cancer tumor cells in tissue culture; the second will test it in solid human tumors growing in mice.

"We have an innovative technique that offers promise for identifying which tumors can be effectively treated with drugs that currently are in clinical trials," Braun said. "If it turns out we can use MEMRI in this way, we could see if a patient's tumor expresses specific calcium channels and then select the best treatment for targeting these particular channels. That would allow us to determine which patients would benefit from these drugs and which drugs will be most therapeutic.

"Not every therapy works against every tumor, and MEMRI may allow us to select the best treatment for a given patient. This technique's major benefits are that it is noninvasive and can quickly lead to individualized therapy."


'/>"/>

Contact: Julie O'Connor
julie.oconnor@wayne.edu
313-577-8845
Wayne State University - Office of the Vice President for Research
Source:Eurekalert

Related medicine news :

1. Wayne State University researcher examines proteins role in diabetic retinopathy
2. Wayne State University researcher seeks to understand link between obesity, flu severity
3. Algae extract increases good cholesterol levels, Wayne State research finds
4. Wayne State develops better understanding of memory retrieval between children and adults
5. Wayne State research team finds possible clue to progression of MS
6. Wayne State researchers say adolescent smoking prevention programs still critical
7. Wayne State University researcher recognized by American Psychological Association
8. CDC funds Wayne State University research to understand, prevent teen dating violence
9. Wayne State researcher finds possible clue to childrens early antisocial behavior
10. Wayne State University researcher to evaluate success of text message diabetes intervention
11. Wayne State embarks on study to improve identification of women at high risk of stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest ... the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity drive ... rare and deadly chromosome abnormality. , After struggling since birth with several health ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor ... on sciatica in a new episode of "Success Files," which is an award-winning ... innovation and investigates each subject in-depth with passion and integrity. , Sciatica occurs ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: